Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis

被引:61
|
作者
Corcoran, Cheryl M. [1 ]
Kimhy, David [1 ]
Stanford, Arielle [1 ]
Khan, Shamir [1 ]
Walsh, Julie [1 ]
Thompson, Judy [1 ]
Schobel, Scott [1 ]
Harkavy-Friedman, Jill [1 ]
Goetz, Ray [1 ]
Colibazzi, Tiziano [1 ]
Cressman, Victoria [1 ]
Malaspina, Dolores [1 ,2 ]
机构
[1] Columbia Univ, Dept Psychiat, New York, NY USA
[2] NYU, Dept Psychiat, New York, NY 10016 USA
关键词
Cannabis; Longitudinal; Prodrome; Psychosis; Risk;
D O I
10.1016/j.schres.2008.08.008
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Cannabis use is reported to increase the risk for psychosis, but no prospective study has longitudinally examined drug use and symptoms concurrently in clinical high risk cases. Method: We prospectively followed for up to 2 years 32 cases who met research criteria for prodromal psychosis to examine the relationship between substance use and clinical measures. Results: Cases with a baseline history of cannabis use (41%) were older, but did not differ in clinical measures. Longitudinal assessments showed these cases had significantly more perceptual disturbances and worse functioning during epochs of increased cannabis use that were unexplained by concurrent use of other drugs or medications. Conclusions: These data demonstrate that cannabis use may be a risk factor for the exacerbation of subthreshold psychotic symptoms, specifically perceptual disturbances, in high risk cases. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:286 / 293
页数:8
相关论文
共 50 条
  • [21] Sub Domains of Negative Symptoms in Individuals at Clinical High Risk for Psychosis
    Azis, Matilda
    Strauss, Gregory P.
    Walker, Elaine
    Mittal, Vijay
    [J]. BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S441 - S441
  • [22] Structure of positive psychotic symptoms in individuals at clinical high risk for psychosis
    Azis, Matilda
    Rouhakhtar, Pamela Rakhshan
    Schiffman, Jason E.
    Ellman, Lauren M.
    Strauss, Gregory P.
    Mittal, Vijay A.
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2021, 15 (03) : 505 - 512
  • [23] Association of Baseline Tumor Necrosis Factor and the Development of Negative Symptoms in Individuals at Clinical High Risk for Psychosis
    Goldsmith, David
    Miller, Andrew
    Addington, Jean
    Bearden, Carrie
    Cadenhead, Kristin
    Cannon, Tyrone
    Cornblatt, Barbara
    Mathalon, Daniel
    McGlashan, Thomas
    Perkins, Diana
    Tsuang, Ming
    Woods, Scott
    Walker, Elaine
    [J]. BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S330 - S331
  • [24] Influence of cannabis use on incidence of psychosis in people at clinical high risk
    Chester, Lucy A.
    Valmaggia, Lucia R.
    Kempton, Matthew J.
    Chesney, Edward
    Oliver, Dominic
    Hedges, Emily P.
    Klatsa, Elise
    Stahl, Daniel
    van der Gaag, Mark
    de Haan, Lieuwe
    Nelson, Barnaby
    McGorry, Patrick
    Amminger, G. Paul
    Riecher-Rossler, Anita
    Studerus, Erich
    Bressan, Rodrigo
    Barrantes-Vidal, Neus
    Krebs, Marie-Odile
    Glenthoj, Birte
    Nordentoft, Merete
    Ruhrmann, Stephan
    Sachs, Gabriele
    McGuire, Philip
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2023, 77 (09) : 469 - 477
  • [25] History of Cannabis Use is Associated with Mismatch Negativity Deficits in Individuals at Clinical High Risk for Psychosis and Healthy Controls
    Park, Chan Y.
    Bachman, Peter
    Belger, Aysenil
    Carrion, Ricardo
    Duncan, Erica
    Johannesen, Jason
    Light, Gregory
    Niznikiewicz, Margaret
    Roach, Brian J.
    Addington, Jean
    Bearden, Carrie
    Cadenhead, Kristin
    Cornblatt, Barbara
    McGlashan, Thomas
    Perkins, Diana
    Seidman, Larry
    Tsuang, Ming
    Walker, Elaine
    Woods, Scott
    Cannon, Tyrone
    Mathalon, Daniel H.
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 358S - 358S
  • [26] Obsessive compulsive symptoms in individuals at clinical risk for psychosis: Association with depressive symptoms and suicidal ideation
    DeVylder, Jordan E.
    Oh, Amy J.
    Ben-David, Shelly
    Azimov, Neyra
    Harkavy-Friedman, Jill M.
    Corcoran, Cheryl M.
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 140 (1-3) : 110 - 113
  • [27] Sleep disturbance, suicidal ideation and psychosis-risk symptoms in individuals at clinical high risk for psychosis
    Cohen, Simon
    Goldsmith, David R.
    Ning, Courtney S.
    Addington, Jean
    Bearden, Carrie E.
    Cadenhead, Kristin S.
    Cannon, Tyrone D.
    Cornblatt, Barbara A.
    Keshavan, Matcheri
    Mathalon, Daniel H.
    Perkins, Diana O.
    Seidman, Larry J.
    Stone, William S.
    Tsuang, Ming T.
    Woods, Scott W.
    Walker, Elaine F.
    Miller, Brian J.
    [J]. PSYCHIATRY RESEARCH, 2024, 341
  • [28] THE ASSOCIATION BETWEEN CANNABIS USE AND SUICIDAL RISK IN PSYCHOSIS
    Serafini, G.
    Pompili, M.
    Innamorati, M.
    Girardi, P.
    [J]. EUROPEAN PSYCHIATRY, 2012, 27
  • [29] Age at onset of cannabis use is associated with age at onset of high risk symptoms for psychosis
    Dragt, S.
    Nieman, D. H.
    Becker, H. E.
    van de Fliert, J. R.
    Dingemans, P. M.
    de Haan, L.
    van Amelsvoort, T. A.
    Linszen, D. H.
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A63 - A63
  • [30] Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis
    Mustonen, Antti
    Niemela, Solja
    Nordstrom, Tanja
    Murray, Graham K.
    Maki, Pirjo
    Jaaskelainen, Erika
    Miettunen, Jouko
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2018, 212 (04) : 227 - 233